Optimizing Antibiotics Prescription

NCT ID: NCT06436690

Last Updated: 2025-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-15

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Interventions that are low-cost, do not add substantially to the physician workload, are consistent with good physician practices and WHO guidelines, and serve as a reminder on the risks of overprescribing antibiotics are critically needed. The overall goal of the proposed project is to test the effect of two behavioral interventions targeted to junior physicians-specifically, requiring them to specify the diagnosis in the prescription note and providing feedback-on their antibiotics prescription rate; examine the intervention's effects across gender and caste; and draw lessons for scaling up the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Antimicrobial resistance (AMR) is one of the top ten threats to global health. Limited existing evidence from Nepal, the site for the proposed study, suggests that physicians "err on the side of caution" by prescribing antibiotics even for viral conditions, which contributes to AMR. Interventions that are low-cost, do not add substantially to the physician workload, are consistent with good physician practices and WHO guidelines, and serve as a reminder on the risks of overprescribing antibiotics are critically needed. The overall goal of the proposed project is to test the effect of a behavioral intervention targeted to junior physicians-specifically, requiring them to specify the diagnosis in the prescription note and providing feedback-on their antibiotics prescription rate; examine the intervention's effects across gender and caste; and draw lessons for scaling up the intervention.

The specific objectives are the following:

Objective 1. Assess the effect of a behavioral intervention targeted to junior physicians on antibiotics prescription rate, including by caste and gender of the patient. A stepped-wedge randomized control trial (RCT) will be conducted among 60 junior physicians in five hospitals (1 government, 2 private teaching, and 2 community) in Nepal. The intervention will be rolled out sequentially across the hospitals and data will be collected from patients (n=3,600) both before and after the intervention. The intervention will consist of three components: (a) a Refresher Training on AMR, (b) a Diagnosis Mandate, and (c) an Individualized Feedback.

Objective 2. Identify barriers to scaling up the intervention beyond the study's site and strategies for their mitigation. After preliminary analysis of the quantitative data, key informant interviews with national- and provincial- level health policy makers (n=5), and in-depth interviews with physicians (n=5) and hospital managers (n=5) will be conducted.

Objective 3. Assess the extent to which physicians prescribe antibiotics correctly. From a subset of patients (n=120, i.e., 2 per physician), more detailed medical information will be collected and analyzed from their outpatient booklet.

This registration is for objective 1. Therefore, only details pertaining to that objective will be provided here.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Antimicrobial Resistance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

CROSSOVER

This is a stepped-wedge randomized controlled trial
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

During this phase, physicians do not receive any intervention.

Group Type NO_INTERVENTION

No interventions assigned to this group

Diagnosis Mandate

In this phase, physicians receive a refresher training on AMR and a letter requiring the physicians to specify the diagnosis in their prescription note.

Group Type EXPERIMENTAL

Diagnosis Mandate

Intervention Type BEHAVIORAL

The intervention consists of: a) a Refresher Training on AMR, and (b) a Diagnosis Mandate.

Feedback

In this phase, physicians receive a customized feedback letter on their prescription behavior, including antibiotics prescription rate.

Group Type EXPERIMENTAL

Individualized Feedback

Intervention Type BEHAVIORAL

Physicians receive a customized feedback on their prescription behavior, including antibiotics prescription rate.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diagnosis Mandate

The intervention consists of: a) a Refresher Training on AMR, and (b) a Diagnosis Mandate.

Intervention Type BEHAVIORAL

Individualized Feedback

Physicians receive a customized feedback on their prescription behavior, including antibiotics prescription rate.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18+
* working at an outpatient clinic in one of the participating hospitals.


* age 18+
* sought care at one of the outpatient clinics in the participating hospitals.

Exclusion Criteria

* \<18 years of age
* working at more than one of the participating hospitals

For patients:


* \<18 years of age
* one of the vulnerable populations (pregnant women, cognitively impaired adults)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Penn State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yubraj Acharya, Ph.D.

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pennsylvania State University

University Park, Pennsylvania, United States

Site Status

Institute for Social and Environmental Research - Nepal

Bharatpur, Bagmati, Nepal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Nepal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00025143

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Anticoagulation Adherence Measurement Strategies
NCT07129395 ACTIVE_NOT_RECRUITING
OptiMEDs Pilot Study
NCT04142645 COMPLETED NA
Improving Wisely - Polypharmacy
NCT03857100 COMPLETED NA
Centralized Prescribing for Statins
NCT05537064 ACTIVE_NOT_RECRUITING NA